Results 171 to 180 of about 365,104 (302)

Physics-based modeling in the new era of enzyme engineering. [PDF]

open access: yesNat Comput Sci
Jurich C, Shao Q, Ran X, Yang ZJ.
europepmc   +1 more source

Therapeutic enzyme engineering using a generative neural network. [PDF]

open access: yesSci Rep, 2022
Giessel A   +7 more
europepmc   +1 more source

Versatile vector tools for efficient protein screening across multiple expression systems

open access: yesFEBS Open Bio, EarlyView.
A unified vector toolkit enables rapid protein expression screening across E. coli, insect, and mammalian cells. A single primer pair amplifies the target gene, which is inserted into any vector via a standardized interface. This streamlined workflow eliminates repeated cloning steps, accelerating the identification of optimal expression conditions for
Zhimin Zhu   +5 more
wiley   +1 more source

Expanding the Repertoire of Photoswitchable Unnatural Amino Acids for Enzyme Engineering. [PDF]

open access: yesAngew Chem Int Ed Engl
Hiefinger C   +11 more
europepmc   +1 more source

Enzyme engineering and in vivo testing of a formate reduction pathway. [PDF]

open access: yesSynth Biol (Oxf), 2021
Wang J   +4 more
europepmc   +1 more source

Time‐restricted feeding prior to Mycobacterium tuberculosis infection reduces tissue CD4+ T cells with limited impact on bacterial clearance

open access: yesFEBS Open Bio, EarlyView.
Time‐restricted feeding (TRF) in mice increased liver fatty acid oxidation and decreased fatty acid biosynthesis. These alterations persisted when TRF was discontinued and the host was infected with Mycobacterium tuberculosis. Pre‐exposure to TRF did not alter tissue (lung and spleen) mycobacterial burden but significantly reduced CD3+ T cells in lungs
Ashish Gupta   +7 more
wiley   +1 more source

From machine learning to multimodal models: The AI revolution in enzyme engineering. [PDF]

open access: yesBiodes Res
Shi Z   +14 more
europepmc   +1 more source

Machine learning for enzyme engineering, selection and design. [PDF]

open access: yesProtein Eng Des Sel, 2021
Feehan R, Montezano D, Slusky JSG.
europepmc   +1 more source

Cyclic azapeptide CD36 ligand attenuates cardiac injury and reduces long‐chain fatty acid accumulation after myocardial ischemia–reperfusion in mice

open access: yesFEBS Open Bio, EarlyView.
In a murine model of myocardial ischemia and reperfusion (MI/R), the CD36 azapeptide ligand MPE‐298 reduces cardiac injury and transiently lowers left ventricular long‐chain fatty acids (LCFAs) accumulation 3 h after reperfusion, accompanied by a decrease of oxidative stress and inflammation‐associated genes' expression in the heart and adipose tissue.
Jade Gauvin   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy